{{Rsnum
|rsid=2279020
|Gene=GABRA1
|Chromosome=5
|position=161895883
|Orientation=plus
|GMAF=0.4174
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=GABRA1
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 45.1 | 41.6 | 13.3
| HCB | 23.7 | 42.2 | 34.1
| JPT | 29.5 | 48.2 | 22.3
| YRI | 37.4 | 47.6 | 15.0
| ASW | 40.4 | 49.1 | 10.5
| CHB | 23.7 | 42.2 | 34.1
| CHD | 17.4 | 58.7 | 23.9
| GIH | 36.6 | 49.5 | 13.9
| LWK | 35.8 | 51.4 | 12.8
| MEX | 36.8 | 47.4 | 15.8
| MKK | 39.4 | 47.7 | 12.9
| TSI | 35.6 | 51.5 | 12.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=20356767
|Title=Association of alpha subunit of GABA(A) receptor subtype gene polymorphisms with epilepsy susceptibility and drug resistance in north Indian population
}}

{{PMID|14569258}} Gender-specific contribution of the GABA(A) subunit genes on 5q33 in methamphetamine use disorder.

{{on chip | Illumina Human 1M}}